Target intelligence / Profile preview

Gut microbiota composition and intestinal epithelial interface

Molecular classification
Biological system, Complex physiological interface
01

Overview

The gut microbiota composition and intestinal epithelial interface represents the complex, bidirectional communication system between the trillions of microorganisms in the gastrointestinal tract and the host's epithelial lining. This interface serves as a critical physical and biochemical barrier that regulates the passage of nutrients and water while preventing the translocation of pathogens and toxins into the systemic circulation (NIH, 2025; MDPI, 2020). The microbiota influences the integrity of this barrier through the production of metabolites, such as short-chain fatty acids (SCFAs), which provide energy to colonocytes and promote the expression of tight junction proteins like zonula occludens-1 (ZO-1) (NIH, 2022). Specialized epithelial cells, including Paneth and goblet cells, further contribute to this interface by secreting antimicrobial peptides and mucins that shape the microbial environment (Karger, 2016; NIH, 2025). Dysregulation of this interface, often characterized by microbial dysbiosis and increased intestinal permeability, is a hallmark of various diseases, including inflammatory bowel disease, metabolic syndrome, and colorectal cancer (MDPI, 2020; NIH, 2025). Therapeutic strategies targeting this system include the use of probiotics, prebiotics, and fecal microbiota transplantation to restore microbial balance and reinforce the intestinal barrier (MDPI, 2024; NIH, 2022). Additionally, the interface plays a vital role in the maturation and regulation of the host's mucosal immune system, making it a focal point for developing precision medicine approaches for gastrointestinal and systemic disorders (NIH, 2022; NIH, 2025).

Other names
Gut-microbiota-epithelial axisIntestinal mucosal barrierGut-host interfaceIntestinal barrier systemMicrobiota-epithelial crosstalk
02

Mechanism of action

Modulation of microbial diversity and abundance, enhancement of tight junction protein expression (e.g., ZO-1, occludin), and production of bioactive metabolites like short-chain fatty acids (SCFAs) to maintain mucosal integrity and regulate host immune responses.

03

Biological functions

Intestinal barrier maintenanceImmune system regulationMetabolic homeostasisPathogen defense (colonization resistance)Nutrient absorption
04

Disease associations

Inflammatory bowel disease (IBD)Irritable bowel syndrome (IBS)ObesityType 2 diabetesColorectal cancerClostridioides difficile infection (CDI)
05

Safety considerations

Risk of systemic infection (bacteremia)Transfer of antibiotic resistance genesUnpredictable host response to microbial modulationLack of regulatory standardization for live biotherapeuticsPotential for inducing or exacerbating dysbiosis
06

Interacting drugs

Rifaximin

5 more in the full profile.

07

Biomarkers

Fecal calprotectinZonulinShort-chain fatty acids (SCFAs)Microbial alpha diversityFirmicutes/Bacteroidetes ratio16S rRNA sequencing profiles

Beyond the preview

Go deeper on Gut microbiota composition and intestinal epithelial interface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gut microbiota composition and intestinal epithelial interface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call